For a copy of this committee's fact sheet, click here.
MISSION
The mission of this subcommittee is to ensure the development of a sound technical basis for alternative tests as a means to reduce, refine, or replace standard fish toxicity test procedures around the globe. The project aims to provide a forum to coordinate the debates and best emerging practices of the fish alternatives and animal model development sciences to meet existing hazard assessment, effluent assessment, risk assessment, classification and labeling, and other regulatory needs.
Pressure on animal testing has traditionally been the purview of mammalian toxicological science, but in the past few years, needs have also emerged in the realm of environmental safety. The issue has been primarily driven by European legislation, including the UK Animal Protection Act, the 7th Amendment to the EU Cosmetics Directive, selected legislation in Germany, and the adopted European chemical legislation known as REACh. Additional ecotoxicity data are sought in many of these legislative efforts, while also promoting non-animal testing / alternative strategies. There is a clear need to develop alternatives that are quicker and use fewer animals. As with higher vertebrate animal alternatives, the balance sought is to reduce animal use without impairing or increasing uncertainty in risk assessment.
The HESI Protein Allergenicity Technical Committee has been engaged in a suite of activities to advance the science related to predicting human allergic potential from exposure to novel proteins and GMOs.
Ø FET Workshop, March 4 - 6, 2008
In collaboration with the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), the subcommittee held an International Workshop on the Application of the Fish Embryo Test as an Animal Alternative Method in Hazard and Risk Assessment and Scientific Research at L'Oreal's facilities in Paris, France.
Chair............................................. Dr. Scott Belanger
HESI Staff................................. Dr. Michelle Embry
For more information, please contact: Michelle Embry at (202) 659-3306 or membry@hesiglobal.org.
AstraZeneca AB
Duke University
European Center for the Validation of Alternative Methods (ECVAM)
L'Oreal
The Procter & Gamble Company
Shell Chemicals, Ltd.
University of Dresden
University of Heidelberg
US Environmental Protection Agency